Security key
75382E109
RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RAPT)
CUSIP: 75382E109
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 33,297,098
- Total 13F value
- $610,504,496
- Share change
- +1,253,755
- Put/Call ratio
- 5%
- SEC-reported price per share
- $18.35
- Number of holders
- 104
- Value change
- +$19,762,513
- Number of buys
- 60
- Number of sells
- 43
- Shares outstanding
- 27,725,634
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
104
Top holders
10
RAPT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
RAPT Therapeutics, Inc. SEC filings
RAPT Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75382E109
Recent filing periods:
Ownership snapshot
Top reported holders of RAPT - RAPT Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
PRICE T ROWE ASSOCIATES INC /MD/ leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Comparable ownership
Top 5
PRICE T ROWE ASSOCIATES INC /MD/
12%
FMR LLC
11%
Column Group LLC
9.7%
STATE STREET CORP
7%
BlackRock Finance, Inc.
6.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
12%
|
$66,625,000
3,364,887 shares
|
— | 31 Dec 2022 |
| FMR LLC |
13F
Company
|
11%
|
$58,453,841
2,952,214 shares
|
— | 31 Dec 2022 |
| Column Group LLC |
13F
Company
|
9.7%
|
$53,076,296
2,680,621 shares
|
— | 31 Dec 2022 |
| STATE STREET CORP |
13F
Company
|
7%
|
$38,426,315
1,940,723 shares
|
— | 31 Dec 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
6.9%
|
$37,689,795
1,903,525 shares
|
— | 31 Dec 2022 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
6.5%
|
$35,619,309
1,798,955 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
104
Shares
33,297,098
Rows available
104
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q4 2025 Across Filers
Q4 2025 holders
3
Q1 2023 holders
104
Holder diff
101
| Investor | Q4 2025 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend